Vimta Labs Ltd

Know More

429.35-4.35 (-1.00%)

03:46 PM,11th Dec 2023

428.00-6.50 (-1.50%)

04:01 PM,11th Dec 2023

BSE : 524394


Sector : Others

ISIN Code : INE579C01029

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Dec 11 2023 | 04:01 PM IST

Market Cap (₹ Cr)


Turnover (₹ Cr)


Volume (Shares)


Face Value


52-WK High


52-WK High Date

25 Aug 2023

52-WK Low


52-WK Low Date

20 Mar 2023

All Time High


All Time High Date

25 Aug 2023

All Time Low


All Time Low Date

13 Mar 2009

Vimta Labs Ltd

Vimta Labs Ltd. established in 1984 is India's most comprehensive contract research and testing organization providing wide range of services to pharmaceutical biopharmaceutical food consumer goods electronic electrical agrochemical healthcare medical device and many other industries. Broadly these services include: Drug discovery development and drug life cycle management support services in the areas of preclinical research (GLP and non-GLP) clinical research central lab and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufacturers processors farmers retailers traders exporters regulators; Clinical diagnostics services to patients clinicians hospitals and Environmental regulatory services such as impact assessments and post project monitoring to industries such as infrastructure power cement oil & gas mining etc. The Company was awarded ISO 9002 Certification under ISO/IEC Guide-25 as Certified Competent Laboratory and Quality Endorsed Company by Standards Australia Quality Assurance Services Pty. Ltd in 1994.In 1997 the Company entered into a Joint Venture with Russian Centre for Testing and Certification ROSTEST Moscow with an investment of 24% of the total Paidup Captial. The main essence of this Joint Venture was to diversify the activities in to preshipment inspection services for all Indian exports to Russia.During 2002 the company begun to offer Clinical Diagnostics Services. Clinical Specialty Diagnostics has been an internal requirement to screen the clinical trial subjects. Facilities were created in the year 2000 to speed up the clinical trials.The Company is now expanding its operations by five times of its existing capacities at S P Biotech Park Genome Valley Turkapally Village Shamirpet Mandal Ranga Reddy Dist. The project is expected to commence from September 2005.During the year 2006-07 the Analytical and Clinical Reference Lab facilities was shifted from the existing Cherlapally Facility to the newly established Life Sciences Facility in S.P.Biotech Park Genome Valley Hyderabad which started commercial operations from September 2006.During the year 2020 Company acquired 100% Equity Shares of Emtac Laboratories Private Limited on 04th March 2020 making Emtac a wholly owned subsidiary of the Company.

Vimta Labs Ltd - Key Fundamentals

Market Cap (₹ Cr)


EPS - TTM (₹) [S]


P/E Ratio (X) [S]


Face Value (₹) 2
Latest Dividend (%)100.00
Latest Dividend Date 21 Jun 2023
Dividend Yield (%) 0.46
Book Value Share (₹) [S]132.90
P/B Ratio (₹) [S]3.23
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)
Quant Small Cap Fund - (G) 13.76 330152 0.12
Quant Small Cap Fund - (IDCW) 13.76 330152 0.12
Quant Small Cap Fund - Direct (G) 13.76 330152 0.12
Quant Small Cap Fund - Direct (IDCW) 13.76 330152 0.12
Motilal Oswal S&P BSE Healthcare ETF 0.00 77 0.04

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High



Week Low/High



Month Low/High



Year Low/High



All time Low/High



Share Price Returns

1 Week2.42%2.30%1.541.50%
1 Month7.22%7.19%7.748.09%
3 Month-24.15%-24.30%4.175.00%
6 Month1.78%1.95%11.2612.68%
1 Year5.28%5.08%12.4613.52%
3 Year153.68%153.38%51.6955.37%

Company Info

Company Information

Executive Chairman : S P Vasireddi

Director (Operation) : V Harriman

Managing Director : Harita Vasireddi

Non-Exec. & Independent Dir. : Y Prameela Rani

Company Sec. & Compli. Officer : Sujani Vasireddi

Non-Exec. & Independent Dir. : G Purnachandra Rao

Non-Exec. & Independent Dir. : Sanjay Dave

Executive Director : Satya Sreenivas Neerukonda

Non-Exec. & Independent Dir. : Yadagiri R Pendri

Registered Office: Plot No 141/2 & 142, IDA Phase II Cherlapally,Hyderabad,Telangana-500051 Ph: 91-40-27264141